Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer.

Shin H, Kim Y, Kim M, Lee Y.

Mol Cells. 2018 Dec 31;41(12):993-999. doi: 10.14348/molcells.2018.0425. Epub 2018 Dec 10. Review.

2.

Biosynthesis of brain cytoplasmic 200 RNA.

Kim Y, Lee J, Shin H, Jang S, Kim SC, Lee Y.

Sci Rep. 2017 Jul 31;7(1):6884. doi: 10.1038/s41598-017-05097-3.

3.

Knockdown of BC200 RNA expression reduces cell migration and invasion by destabilizing mRNA for calcium-binding protein S100A11.

Shin H, Lee J, Kim Y, Jang S, Lee Y, Kim S, Lee Y.

RNA Biol. 2017 Oct 3;14(10):1418-1430. doi: 10.1080/15476286.2017.1297913. Epub 2017 Mar 1.

4.

Identifying the cellular location of brain cytoplasmic 200 RNA using an RNA-recognizing antibody.

Shin H, Lee J, Kim Y, Jang S, Ohn T, Lee Y.

BMB Rep. 2017 Jun;50(6):318-322.

5.

Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2.

Jang S, Shin H, Lee J, Kim Y, Bak G, Lee Y.

FEBS Lett. 2017 Jan;591(2):393-405. doi: 10.1002/1873-3468.12544. Epub 2017 Jan 12.

6.

Truncated SRA RNA derivatives inhibit estrogen receptor-α-mediated transcription.

Jung E, Jang S, Lee J, Kim Y, Shin H, Park HS, Lee Y.

Mol Biol Rep. 2016 Oct;43(10):1019-25. doi: 10.1007/s11033-016-4039-2. Epub 2016 Jul 12.

PMID:
27406387

Supplemental Content

Loading ...
Support Center